As early as the 1910’s the first generation owner of Chi Fu Mr. J.T. Hsu served as an apprentice in a pharmacy owned by a Japanese in Tainan.
In the 1920’s Mr. J.T. Hsu established his own pharmacy. And in the 1930’s he was a well known pharmaceutical wholesaler in the southern region of Taiwan.
During the Japanese colonial times, pharmaceutical and chemical products must be imported through Japanese trading companies.
In the 1930’s，Mr. J.T. Hsu imported British Chemical giant, Imperial Chemical Industrial (ICI)’s products via Shanghai and HK into Taiwan.
AfterWorld War II, “SanHo” Trading Company was established in 1049 by Mr. J. T. Hsu with 2 other partners. It was to import pharmaceuticals products from the UK, US and Japan.
Chi Fu was incorporated in 1958 and began operation in 1961. Mr. J.T. Hsu and his eldest son, Mr. Robert Hsu incorporated the company in order to import pharmaceuticals into Taiwan.
At that time, Taiwan had foreign currency exchange restriction. Only reputable companies with good standings may purchase foreign currencies. Only those companies are allowed to have the word “Trading” in their company names. Chi Fu was no exception. We see this as a great tradition.
Second Generation owner, Mr. Robert Hsu borden the scope. During the 1970’s as MNC’s began to set up branch offices in Taiwan, Mr. Robert Hsu began to help more and more companies to market their goods in Taiwan. Mr. Robert Hsu helped many of the MNC’s such as Burrough Wellcome, Zeneca, Aventis, Park Davis, Rhone-Poulenc and Hoechst to market their products in Taiwan.
In the 1980s and 1990’s came the period of tremendous growth for Taiwanese pharmaceutical market. Government reimbursement and subsequent universal healthcare. Chi Fu also grew rapidly during this time to include many different sales teams for different therapeutical areas.
In the 2000’s in preparation of the wave of patent expiration in the pharmaceutical market, Chi Fu branched out to work with Indian generic companies. During this time period, Chi Fu registered the first finished formulation product from India and Cyprus.
The third generation owner, Mr. Wayne Hsu, after successful careers in the field of biotechnology in the United States, joined his father, Mr. Robert Hsu in 2008 after the passing of Wayne’s mother. Wayne and his sister established a not for profit memorial foundation to help bring newer technologies to treat liver cancer.
In the 2010’s, Chifu initiated more innovation. Chi Fu expended it’s medical device products range to include all ablation product line from AngioDynamics (RFA, Microwave, NanoKnife) and began to market finished formulation from Bangladesh and United Arab Emeritus. Chi Fu also registered the first Oral Dissolvable Film (ODF) dosage form from a Korean supplier.
In the 2020’s Chi Fu will find more ways to be innovative and combine the effort with the memorial foundation Mr. Wayne Hsu has established in the honor of his mother to help more people and bring the best of the world to Taiwan.